November 2024 FDA Recall Lisinopril by Evaric Pharmaceuticals Inc.
D-0061-2025 - Presence of Foreign Object

This Class II drug recall was voluntarily initiated by Evaric Pharmaceuticals Inc. on November 15, 2024 for the product Lisinopril. The FDA reported the reason for recall as presence of foreign object. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0061-2025

Reason for Recall
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Initiated
11-15-2024
Reported
11-27-2024
Quantity
222, 600 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Evaric Pharmaceuticals Inc.
Nationwide in the USA
Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.

Batch or Lot Expiration Information

Lot# : 241103, exp. date 05/31/2026